-2017-
1. Mitsutoshi Oguri, Kimihiko Kato, Tetsuo Fujimaki, Hideki Horibe, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of five genetic variants as novel determinants of type 2 diabetes mellitus in Japanese by exome-wide association studies.
   Scientific Sessions 2017 of American Heart Association, Anaheim, USA, November 11-15, 2017.

2. Mitsutoshi Oguri, Kimihiko Kato, Tetsuo Fujimaki, Hideki Horibe, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of eight genetic variants as novel determinants of dyslipidemia in Japanese by exome-wide association studies.
   Scientific Sessions 2017 of American Heart Association, Anaheim, USA, November 11-15, 2017.

3. Mitsutoshi Oguri, Kimihiko Kato, Tetsuo Fujimaki, Hideki Horibe, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies.
   Scientific Sessions 2017 of American Heart Association, Anaheim, USA, November 11-15, 2017.

4. Kimihiko Kato, Hideki Horibe, Mitsutoshi Oguri, Tetsuo Fujimaki, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of EGFLAM, SPATC1L, and RNASE13 as novel susceptibility loci for aortic aneurysm in Japanese individuals by exome-wide association studies.
   European Society of Cardiology Congress 2017, Barcelona, Spain, August 26-30, 2017.

5. Hideki Horibe, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of TNFSF13, SPATC1L, SLC22A25, and SALL4 as novel susceptibility loci for atrial fibrillation in Japanese individuals by an exome-wide association study.
   European Society of Cardiology Congress 2017, Barcelona, Spain, August 26-30, 2017.

6. Hideki Horibe, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimaki, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of 12q24.1, ACAD10, and BRAP as novel genetic determinants of blood pressure in Japanese individuals by exome-wide association studies.
   European Society of Cardiology Congress 2017, Barcelona, Spain, August 26-30, 2017.

7. Kimihiko Kato, Hideki Horibe, Mitsutoshi Oguri, Tetsuo Fujimaki, Jun Sakuma, Ichiro Takeuchi, Toyoaki Murohara, Yoshiki Yasukochi, Yoshiji Yamada.
   Identification of STXBP2 as a novel susceptibility locus for myocardial infarction in Japanese individuals by an exome-wide association study.
   European Society of Cardiology Congress 2017, Barcelona, Spain, August 26-30, 2017.

-2016-
8. Takuya Sumi, Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Toyoaki Murohara, Kota Matsui, Ichiro Takeuchi, Yoshiji Yamada.
   Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study.
   European Society of Cardiology Congress 2016, Rome, Italy, August 27-31, 2016.

9. Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Toyoaki Murohara, Kota Matsui, Ichiro Takeuchi, Yoshiji Yamada.
   Association of genetic variants with dyslipidemia and chronic kidney disease in a longitudinal population-based genetic epidemiological study.
   European Society of Cardiology Congress 2016, Rome, Italy, August 27-31, 2016.

10. Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Toyoaki Murohara, Kota Matsui, Ichiro Takeuchi, Yoshiji Yamada.
    Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study.
    European Society of Cardiology Congress 2016, Rome, Italy, August 27-31, 2016.

11. Mitsutoshi Oguri, Takuya Sumi, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Toyoaki Murohara, Kota Matsui, Ichiro Takeuchi, Yoshiji Yamada.
    Obesity-related changes in clinical parameters and conditions in a longitudinal population-based epidemiological study.
    European Society of Cardiology Congress 2016, Rome, Italy, August 27-31, 2016.

12. Kimihiko Kato, Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Toyoaki Murohara, Yoshiji Yamada.
    Age-related changes in clinical parameters and their relations to common complex diseases in community-dwelling Japanese individuals.
    European Society of Cardiology Congress 2016, Rome, Italy, August 27-31, 2016.

13. Kimihiko Kato, Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Toyoaki Murohara, Yoshiji Yamada.
    Association of a polymorphism of the butyrophilin, subfamily 2, member A1 gene with hypertension in community-dwelling Japanese individuals.
    European Society of Cardiology Congress 2016, Rome, Italy, August 27-31, 2016.

-2015-
14. David Duverle, Shohei Kawasaki, Yoshiji Yamada, Jun Sakuma, Koji Tsuda.
    Privacy-preserving statistical analysis by exact logistic regression.
    PRIVAGEN 2015, Tokyo, Japan, September 8, 2015.

15. Wenjie Lu, Yoshiji Yamada, Jun Sakuma.
    Efficient Secure Outsourcing of Genome-wide Association Studies.
    PRIVAGEN 2015, Tokyo, Japan, September 8, 2015.

16. Kimihiko Kato, Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of genetic variants with atrial fibrillation in Japanese individuals.
    European Society of Cardiology Congress 2015, London, United Kingdom, August 29-September 2, 2015.

17. Hideki Horibe, Chikara Ueyama, Yuichiro Yamase, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Masazumi Arai, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of polymorphisms of FURIN and ZPR1 with metabolic syndrome in Japanese individuals.
    European Society of Cardiology Congress 2015, London, United Kingdom, August 29-September 2, 2015.

18. Hideki Horibe, Yuichiro Yamase, Chikara Ueyama, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Masazumi Arai, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of polymorphisms of TOMM40 and SLC22A4 with ischemic stroke.
    European Society of Cardiology Congress 2015, London, United Kingdom, August 29-September 2, 2015.

19. Mitsutoshi Oguri, Tetsuo Fujimaki, Hideki Horibe, Kimihiko Kato, Toyoaki Murohara, Kota Matsui, Ichiro Takeuchi, Yoshiji Yamada.
    Association of genetic variants of the alpha-kinase 1 gene with type 2 diabetes mellitus in a longitudinal population-based genetic epidemiological study.
    European Society of Cardiology Congress 2015, London, United Kingdom, August 29-September 2, 2015.

20. Wenjie Lu, Yoshiji Yamada, Jun Sakuma.
    Efficient secure outsourcing of genome-wide association studies.
    2nd International Workshop on Genome Privacy and Security (GenoPri'15), San Jose, CA, USA, May 21, 2015.

21. David A. duVerle, Shohei Kawasaki, Yoshiji Yamada, Jun Sakuma, Koji Tsuda.
    Privacy-Preserving Statistical Analysis by Exact Logistic Regression.
    2nd International Workshop on Genome Privacy and Security (GenoPri'15), San Jose, CA, USA, May 21, 2015.

-2014-
22. Mitsutoshi Oguri, Yoshiji Yamada.
    Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.
    19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medicine. Athens, Greece, October 9-11, 2014.

23. Yoshiji Yamada, Mitsutoshi Oguri.
    Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals.
    19th World Congress on Advances in Oncology and 17th International Symposium on Molecular Medicine. Athens, Greece, October 9-11, 2014.

24. Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Reiko Matsuoka, Shintaro Abe, Fumitaka Tokoro, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Yoshiji Yamada.
    Association of a polymorphism of the transcription factor 21 gene (TCF21) with hypertension in Japanese individuals.
    European Society of Cardiology Congress 2014, Barcelona, Spain, August 30-September 3, 2014.

25. Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Kimihiko Kato, Yoshiji Yamada.
    Association of genetic variants of the alpha-kinase 1 gene (ALPK1) with type 2 diabetes mellitus in community-dwelling Japanese individuals.
    European Society of Cardiology Congress 2014, Barcelona, Spain, August 30-September 3, 2014.

26. Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Kimihiko Kato, Yoshiji Yamada.
    Association of genetic variants of the alpha-kinase 1 gene (ALPK1) with myocardial infarction in community-dwelling Japanese individuals.
    European Society of Cardiology Congress 2014, Barcelona, Spain, August 30-September 3, 2014.

27. Reiko Matsuoka, Shintaro Abe, Fumitaka Tokoro, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada.
    Association of genetic variants of the phosphatase and actin regulator 1 gene (PHACTR1) and the CDKN2B antisense RNA 1 (CDKN2BAS1) with coronary heart disease in Japanese individuals.
    European Society of Cardiology Congress 2014, Barcelona, Spain, August 30-September 3, 2014.

28. Shintaro Abe, Fumitaka Tokoro, Reiko Matsuoka, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada.
    Association of a polymorphism of the zinc finger protein 259 gene (ZNF259) with dislipidemia in Japanese individuals.
    European Society of Cardiology Congress 2014, Barcelona, Spain, August 30-September 3, 2014.

29. Fumitaka Tokoro, Reiko Matsuoka, Shintaro Abe, Masazumi Arai, Toshiyuki Noda, Sachiro Watanabe, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Yoshiji Yamada.
    Association of a genetic variant of the zinc finger protein 259 gene (ZNF259) with type 2 diabetes mellitus in Japanese individuals.
    European Society of Cardiology Congress 2014, Barcelona, Spain, August 30-September 3, 2014.

-2013-
30. Kimihiko Kato, Tetsuo Fujimaki, Mitsutoshi Oguri, Hideki Horibe, Sachiro Watanabe, Toyoaki Murohara, Motoji Sawabe, Tamotsu Nishida, Sahoko Ichihara, Yoshiji Yamada.
    Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association study.
    European Society of Cardiology Congress 2013, Amsterdam, Netherlands, August 31-September 4, 2013.

31. Mitsutoshi Oguri, Motoji Sawabe, Hideki Horibe, Toyoaki Murohara, Kimihiko Kato, Tamotsu Nishida, Yoshiji Yamada.
    Genome-wide analysis of DNA methylation in human atherosclerosis.
    European Society of Cardiology Congress 2013, Amsterdam, Netherlands, August 31-September 4, 2013.

32. Hideki Horibe, Chikara Ueyama, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Toyoaki Murohara, Sahoko Ichihara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with dislipidemia in community-dwelling Japanese individuals.
    European Society of Cardiology Congress 2013, Amsterdam, Netherlands, August 31-September 4, 2013.

33. Hideki Horibe, Chikara Ueyama, Tetsuo Fujimaki, Mitsutoshi Oguri, Kimihiko Kato, Toyoaki Murohara, Sahoko Ichihara, Yoshiji Yamada.
    Association of polymorphisms of CELSR1 and chromosome 3q28 with hypertension in community-dwelling Japanese individuals.
    European Society of Cardiology Congress 2013, Amsterdam, Netherlands, August 31-September 4, 2013.

-2012-
34. Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with myocardial infarction and intermediate phenotypes in Japanese individuals.
    The 1st International Congress on Lipid Metabolism & Atherosclerosis 2012, Seoul, Korea, September 14-15, 2012.

35. Kimihiko Kato, Yoshiyuki Tokuda, Naohiko Inagaki, Tetsuro Yoshida, Tetsuo Fujimaki, Mitsutoshi Oguri, Takeshi Hibino, Kiyoshi Yokoi, Toyoaki Murohara, Yoshiji Yamada.
    Association of a matrix metallopeptidase 1 gene polymorphism with long-term outcome of thoracic aortic aneyrysm.
    European Society of Cardiology Congress 2012, Munich, Germany, August 25-29, 2012.

36. Mitsutoshi Oguri, Yoshihisa Shibata, Haruo Kamiya, Mizuho Hiramatsu, Tetsuo Fujimaki, Kimihiko Kato, Toyoaki Murohara, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Effects of combined genotypes for polymorphisms of APOA5 and BTN2A1 on metabolic syndrome in East Asian populations.
    European Society of Cardiology Congress 2012, Munich, Germany, August 25-29, 2012.

37. Mitsutoshi Oguri, Yoshihisa Shibata, Haruo Kamiya, Mizuho Hiramatsu, Hideki Horibe, Kimihiko Kato, Toyoaki Murohara, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia in East Asian populations.
    European Society of Cardiology Congress 2012, Munich, Germany, August 25-29, 2012.

-2011-
38. Yoshiji Yamada, Mizuho Hiramatsu.
    Association of genetic variants with myocardial infarction and intermediate phenotypes in East Asian populations.
    16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine, Rhodes, Greece, October 6-8, 2011.

39. Mizuho Hiramatsu, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus, hypertension, and chronic kidney disease in Japanese individuals.
    16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine, Rhodes, Greece, October 6-8, 2011.

40. Yoshiji Yamada.
    Identification of BTN2A1 as a susceptibility gene for myocardial infarction in Japanese individuals by a genome-wide association study.
    XXIIIth Congress of the International Society on Thrombosis and Haemostasis, Kyoto, Japan, July 23-28, 2011.

41. Mitsutoshi Oguri, Tetsuro Yoshida, Tetsuo Fujimaki, Kimihiko Kato, Hideki Horibe, Sachiro Watanabe, Toyoaki Murohara, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with myocardial infarction and dyslipidemia in East Asian populations.
    European Society of Cardiology Congress 2011, Paris, France, August 27-31, 2011.

42. Mitsutoshi Oguri, Yoshihisa Shibata, Haruo Kamiya, Tetsuo Fujimaki, Kimihiko Kato, Hideki Horibe, Toyoaki Murohara, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada.
    Association of a genetic variant of BTN2A1 with metabolic syndrome in East Asian populations.
    European Society of Cardiology Congress 2011, Paris, France, August 27-31, 2011.

43. Toshiki Kawamiya, Tetsuro Yoshida, Hideki Horibe, Kiyoshi Yokoi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimiaki, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individuals.
    European Society of Cardiology Congress 2011, Paris, France, August 27-31, 2011.

44. Toshiki Kawamiya, Tetsuro Yoshida, Hideki Horibe, Kiyoshi Yokoi, Kimihiko Kato, Mitsutoshi Oguri, Tetsuo Fujimiaki, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of polymorphisms of BTN2A1 or ILF3 with myocardial infarction in Japanese individuals with different lipid profiles.
    European Society of Cardiology Congress 2011, Paris, France, August 27-31, 2011.

45. Kimihiko Kato, Tetsuro Yoshida, Mitsutoshi Oguri, Hideki Horibe, Toshiki Kawamiya, Kiyoshi Yokoi, Tetsuo Fujimaki, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus, or chronic kidney disease.
    European Society of Cardiology Congress 2011, Paris, France, August 27-31, 2011.

46. Kimihiko Kato, Tetsuo Fujimaki, Mitsutoshi Oguri, Tetsuro Yohida, Hideki Horibe, Sachiro Watanabe, Toyoaki Murohara, Jong Ho Lee, Yangsoo Jang, Yoshiji Yamada. ,br/> Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations.
    European Society of Cardiology Congress 2011, Paris, France, August 27-31, 2011.

-2010-
47. Yoshiji Yamada.
    Association of genetic variants with myocardial infarction, dyslipidenmia, and metabolic syndrome in East Asian populations.
    The 8th International Diabetes Federation Western Pacific Region Congress, Busan, Korea, October 17-20, 2010.

48. Yoshiji Yamada.
    Association of genetic variants with myocardial infarction and intermediate phenotypes in East Asian populations.
    The 7th International Symposium of Korea Biomedical Genomic Research Association and Center for Genomic Science, Seoul, Korea, November 26, 2010.

49. Toshiki Kawamiya, Tetsuro Yoshida, Kimihiko Kato, Tetsuo Fujimaki, Hideki Horibe, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with different lipid profiles.
    European Society of Cardiology Congress 2010, Stockholm, Sweden, August 28 - September 1, 2010.

50. Toshiki Kawamiya, Tetsuro Yoshida, Kimihiko Kato, Tetsuo Fujimaki, Hideki Horibe, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of genetic variants with ischemic stroke in Japanese individuals with or without metabolic syndrome.
    European Society of Cardiology Congress 2010, Stockholm, Sweden, August 28 - September 1, 2010.

51. Toshiki Kawamiya, Kimihiko Kato, Tetsuo Fujimaki, Hideki Horibe, Kiyoshi Yokoi, Tetsuro Yoshida, Mitsutoshi Oguri, Sachiro Watanabe, Toyoaki Murohara, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with or without metabolic syndrome.
    European Society of Cardiology Congress 2010, Stockholm, Sweden, August 28 - September 1, 2010.

52. Hideki Horibe, Toshiki Kawamiya, Kiyoshi Yokoi, Kimihiko Kato, Tetsuro Yoshida, Tetsuo Fujimaki, Mitsutoshi Oguri, Haruo Kamiya, Miyoshi Ohno, Sachiro Watanabe, Kei Satoh, Masashi Tanaka, Yoshinori Nozawa, Genjiro Kimura, Toyoaki Murohara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with hypertension in Japanese individuals.
    The 83th Scientific Sessions of American Heart Association, Chicago, USA, November 13-17, 2010.

53. Mizuho Hiramatsu, Mitsutoshi Oguri, Yoshihisa Shibata, Haruo Kamiya, Miyoshi Ohno, Tetsuro Yoshida, Tetsuo Fujimaki, Kimihiko Kato, Hideki Horibe, Toshiki Kawamiya, Kiyoshi Yokoi, Sachiro Watanabe, Kei Satoh, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Association of a polymorphism of BTN2A1 with type 2 diabetes mellitus in Japanese individuals.
    The 83th Scientific Sessions of American Heart Association, Chicago, USA, November 13-17, 2010.

-2009-
54. Yoshiji Yamada.
    Identification of CELSR1 as a susceptibility gene for ischemic stroke in Japanese individuals by a genome-wide association study.
    The 12th Cardiovascular Genomics and Atherosclerosis Symposium, Seoul, Korea, October 16-17, 2009.

55. Yoshiji Yamada.
    Identification of new susceptibility genes for myocardial infarction by a genome-wide association study.
    The 12th Cardiovascular Genomics and Atherosclerosis Symposium, Seoul, Korea, October 16-17, 2009.

56. Sahoko Ichihara, Yoshiji Yamada, Gaku Ichihara, Tamie Nakajima, Frank J. Gonzalez, Toyoaki Murohara.
    Inhibition of ischemia-induced angiogenesis by benzo[a]pyrene in a manner dependent on the aryl hydrocarbon receptor.
    The 48th Annual Meeting of the Society of Toxicology, Baltimore, USA, March, 2009

57. Kazuhiro Yajima, Tetsuro Yoshida, Sachiro Watanabe, Kimihiko Kato, Tetsuo Fujimaki, Takeshi Hibino, Kiyoshi Yokoi, Toyoaki Murohara, Genjiro Kimura, Yoshiji Yamada.
    Association of a polymorphism of the apolipoprotein E gene with chronic kidney disease in Japanese individuals with metabolic syndrome.
    European Society of Cardiology Congress 2009, Barcelona, Spain, August 29 - September 2, 2009.

58. Tetsuo Fujimaki, Kimihiko Kato, Toshiki Kawamiya, Satoru Tanaka, Kazuhiro Yajima, Takeshi Hibino, Kiyoshi Yokoi, Toyoaki Murohara, Genjiro Kimura, Yoshiji Yamada.
    Association of genetic variants with myocardial infarction in Japanese individuals with chronic kidney disease.
    European Society of Cardiology Congress 2009, Barcelona, Spain, August 29 - September 2, 2009.

59. Kimihiko Kato, Tetsuro Yoshida, Yoshiji Yamada, Kiyoshi Yokoi, Mitsutoshi Oguri, Kazuhiro Yajima, Tetsuo Fujimaki, Takeshi Hibino, Genjiro Kimura, Toyoaki Murohara.
    Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension.
    European Society of Cardiology Congress 2009, Barcelona, Spain, August 29 - September 2, 2009.

60. Kimihiko Kato, Yoshiji Yamada, Mitsutoshi Oguri, Kiyoshi Yokoi, Kazuhiro Yajima, Tetsuo Fujimaki, Takeshi Hibino, Tetsuro Yoshida, Genjiro Kimura, Toyoaki Murohara.
    Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome.
    European Society of Cardiology Congress 2009, Barcelona, Spain, August 29 - September 2, 2009.

61. Tetsuo Fujimaki, Kimihiko Kato, Kazuhiro Yajima, Takeshi Hibino, Kiyoshi Yokoi, Mitsutoshi Oguri, Tetsuro Yoshida, Norifumi Metoki, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Genjiro Kimura, Toyoaki Murohara, Yoshiji Yamada.
    Prediction of genetic risk for myocardial infarction in Japanese individuals.
    The 82th Scientific Sessions of American Heart Association, Orlando, USA, November 14-18, 2009.

62. Tetsuo Fujimaki, Kimihiko Kato, Kazuhiro Yajima, Takeshi Hibino, Kiyoshi Yokoi, Mitsutoshi Oguri, Tetsuro Yoshida, Norifumi Metoki, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Genjiro Kimura, Toyoaki Murohara, Yoshiji Yamada.
    Genetic risk for myocardial infarction in Japanese individuals with or without chronic kidney disease.
    The 82th Scientific Sessions of American Heart Association, Orlando, USA, November 14-18, 2009.

63. Yumiko Yamamura, Mitsutoshi Oguri, Yoshihisa Shibata, Haruo Kamiya, Miyoshi Ohno, Kimihiko Kato, Kiyoshi Yokoi, Tetsuro Yoshida, Sachiro Watanabe, Norifumi Metoki, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Assessment of genetic risk for hypertension in Japanese individuals.
    The 82th Scientific Sessions of American Heart Association, Orlando, USA, November 14-18, 2009.

64. Mitsutoshi Oguri, Takanori Nagahiro, Yoshiyuki Kataoka, Haruo Kamiya, Miyoshi Ohno, Tetsuro Yoshida, Kimihiko Kato, Kiyoshi Yokoi, Sachiro Watanabe, Norifumi Metoki, Kei Satoh, Yukitoshi Aoyagi, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Genetic variants that confer susceptibility to myocardial infarction differ among individuals with or without hypertension or diabetes mellitus.
    The 82th Scientific Sessions of American Heart Association, Orlando, USA, November 14-18, 2009.

-2008-
65. Yoshiji Yamada.
    Genetic risk for metabolic syndrome, chronic kidney disease, and cardiovascular disease.
    The 2008 Scientific Conference of the Korean Society of Lipiodology and Atherosclerosis, Seoul, Korea, September 6, 2008.

66. Yoshiji Yamada.
    Identification of the genetic risk for myocardial infarction and ischemic stroke by candidate gene approach and genome-wide association study.
    The 11th Cardiovascular Genomics and Atherosclerosis Symposium, Seoul, Korea, October 31, 2008.

67. Kazuhiro Yajima, Yoshiji Yamada, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sachiro Watanabe, Sahoko Ichihara, Yoshinori Nozawa, Toyoaki Murohara, Genjiro Kimura.
    Genetic risk for myocardial infarction determined by polymorphisms of candidate genes in Japanese individuals.
    European Society of Cardiology Congress 2008, Munich, Germany, August 30 - September 3, 2008.

68. Kazuhiro Yajima, Yoshiji Yamada, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sachiro Watanabe, Sahoko Ichihara, Yoshinori Nozawa, Toyoaki Murohara, Genjiro Kimura.
    Genetic risk for metabolic syndrome.
    European Society of Cardiology Congress 2008, Munich, Germany, August 30 - September 3, 2008.

69. Sahoko Ichihara, Gaku Ichihara, Fang Liu, Toyoaki Murohara, Yoshiji Yamada.
    Ablation of Nrf2 resulted in acceleration of ischemia-induced angiogenesis.
    The 81th Scientific Sessions of American Heart Association, New Orleans, USA, November 8-12, 2008.

70. Mitsutoshi Oguri, Haruo Kamiya, Miyoshi Ohno, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Kimihiko Kato, Kiyoshi Yokoi, Sachiro Watanabe, Yukitoshi Aoyagi, Masashi Tanaka, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals.
    The 81th Scientific Sessions of American Heart Association, New Orleans, USA, November 8-12, 2008.

-2007-
71. Yoshiji Yamada.
    Genetic risk for metabolic syndrome and atherosclerotic diseases.
    10th Cardiovascular Genomics and Atherosclerosis Symposium, Yonsei University, Seoul, Korea, April 13, 2007.

72. Yoshiji Yamada.
    Prediction of genetic risk for metabolic syndrome and atherosclerotic disease.
    The 4th International Joint Symposium of Korea Biomedial Genomic Research Association and Center for Genomic Science, Seoul, Korea, December 7, 2007.

73. Yoshiji Yamada.
    Prediction of genetic risk for myocardial infarction and stroke.
    12th World Congress on Advances in Oncology and 10th International Symposium on Molecular Medicine, Crete, Greece, October 11-13, 2007.

74. Kimihiko Kato, Kiyoshi Yokoi, Yoshiji Yamada.
    Prediction of genetic risk for atrial fibrillation and in-stent restenosis.
    12th World Congress on Advances in Oncology and 10th International Symposium on Molecular Medicine, Crete, Greece, October 11-13, 2007.

75. Mitsutoshi Oguri, Kimihiko kato, Kazuhiro Yajima, Takeshi Hibino, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Yutaka Nishigaki , Noriyuki Fuku , Sachiyo Yamaguchi, Yoshinori Nozawa, Masashi Tanaka, Yoshiji Yamada.
    Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males.
    The 56th Annual Scientific Session of American College of Cardiology, New Orleans, USA, March 2007.

76. Yutaka Nishigaki, Yoshiji Yamada, Noriyuki Fuku, Masashi Tanaka.
    Women with mitochondrial haplogroup A are susceptible to atherothrombotic cerebral infarction.
    The 59th American Academy of Neurology Annual Meeting, Hynes Convention Center, Boston, USA, April 28-May 5, 2007.

77. Kazuhiro Yajima, Yoshiji Yamada, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Sahoko Ichihara, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Yoshinori Nozawa.
    Genetic risk for myocardial infarction.
    13th World Congress on Heart Disease: International Academy of Cardiology Annual Scientific Sessions 2007, Vancouver, Canada, July 28-31, 2007.

78. Kimihiko Kato, Mitsutoshi Oguri, Takeshi Hibino, Kiyoshi Yokoi, Tomonori Segawa, Hitoshi Matsuo, Sachiro Watanabe, Yoshinori Nozawa, Toyoaki Murohara, Yoshiji Yamada.
    Genetic risk for restenosis after coronary stenting.
    European Society of Cardiology Congress 2007, Vienna, Austria, September 1-5, 2007.

79. Tetsuro Yoshida, Kazuhiro Yajima, Takeshi Hibino, Kimihiko Kato, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Mitsutoshi Oguri, Shunsuke Murai, Kiyoshi Yokoi, Genjiro Kimura, Yoshiji Yamada.
    Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.
    European Society of Cardiology Congress 2007, Vienna, Austria, September 1-5, 2007.

80. Kazuhiro Yajima, Sahoko Ichihara, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Takashi Kameyama, Kiyoshi Yokoi, Yoshinori Nozawa, Yoshiji Yamada.
    Assessment of genetic factors for obesity.
    European Society of Cardiology Congress 2007, Vienna, Austria, September 1-5, 2007.

81. Mitsutoshi Oguri, Kimihiko Kato, Tetsuro Yoshida, Takeshi Hibino, Kazuhiro Yajima, Tetsuo Fujimaki, Kiyoshi Yokoi, Hitoshi Matsuo, Shunichiro Warita, Tomonori Segawa, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa, Sahoko Ichihara, Yoshiji Yamada.
    Genetic risk for low HDL-cholesterol or high LDL-cholesterol concentration.
    The 80th Scientific Sessions of American Heart Association, Orlando, USA, November 4-7, 2007.

82. Kimihiko Kato, Mitsutoshi Oguri, Tetsuro Yoshida, Takeshi Hibino, Kazuhiro Yajima, Tetsuo Fujimaki, Kiyoshi Yokoi, Hitoshi Matsuo, Shunichiro Warita, Tomonori Segawa, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Akitomo Yasunaga, Hyuntae Park, Masashi Tanaka, Yoshinori Nozawa, Sahoko Ichihara, Yoshiji Yamada.
    Assessment of genetic risk for hypertriglyceridemia.
    The 80th Scientific Sessions of American Heart Association, Orlando, USA, November 4-7, 2007.

83. Kimihiko Kato, Mitsutoshi Oguri, Tetsuro Yoshida, Takeshi Hibino, Kazuhiro Yajima, Tetsuo Fujimaki, Kiyoshi Yokoi, Hitoshi Matsuo, Shunichiro Warita, Tomonori Segawa, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa, Sahoko Ichihara, Yoshiji Yamada.
    Assessment of genetic risk for thoracic aortic aneurysm among hypertensive patients.
    The 80th Scientific Sessions of American Heart Association, Orlando, USA, November 4-7, 2007.

84. Sahoko Ichihara, Gaku Ichihara, Toyoaki Murohara, Yoshiji Yamada.
    Protective effect of metallothionein in ischemic hindlimb against oxidative stress induced by benzo[a]pyrene.
    The 80th Scientific Sessions of American Heart Association, Orlando, USA, November 4-7, 2007.

-2006-
85. Yoshiji Yamada.
    Prediction of the genetic risk for myocardial infarction and stroke.
    5th Congress of Asian Pacific Society of Atherosclerosis and Vascular Diseases, Jeju, Korea, April 12-15, 2006.

86. Yoshiji Yamada.
    Genetic risk of myocardial infarction and stroke.
    2nd Joint International Symposium of Yonsei University Research Institute of Science for Aging and Cardiovascular Genome Center, Yonsei University, Seoul, Korea, May 20, 2006.

87. Masashi Tanaka, Yutaka Nishigaki, Noriyuki Fuku, Yoshiji Yamada.
    Polymorphisms and mutations of mitochondrial genome contribute to human aging and degenerative diseases.
    Mitochondrial symposium and workshop, Kaohsiung, Taiwan, August 5, 2006.

88. Sahoko Ichihara, Yoshiji Yamada, Koji Obata, Kohzo Nagata, Akiko Noda, Gaki Ichihara, Hideo Izawa, Toyoaki Murohara, Mitsuhiro Yokota.
    Attenuation of left ventricular dysfunction by a peroxisome proliferator-activated receptor-alpha agonist in hypertensive rats is asociated with downregulation of redox-regulated transcription factors.
    The 55th Annual Scientific Session of American College of Cardiology, Atlanta, USA, March 2006.

89. Kimihiko Kato, Yoshiji Yamada, Takeshi Hibino, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Assessment of genetic risk for myocardial infarction.
    World Congress of Cardiology 2006, Barcelona, Spain, September 2006.

90. Kazuhiro Yajima, Yoshiji Yamada, Kohta Nishihama, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Association of gene polymorphisms with myocardial infarction among men or women or among individuals with or without conventional coronary risk factors.
    The 79th Scientific Sessions of American Heart Association, Chicago, USA, November 2006.

91. Mitsutoshi Oguri, Kimihiko Kato, Kazuhiro Yajima, Takeshi Hibino, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Sahoko Ichihara, Takashi Kameyama, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Yoshinori Nozawa, Yoshiji Yamada.
    Genetic risk for lone atrial fibrillation.
    The 79th Scientific Sessions of American Heart Association, Chicago, USA, November 2006.

92. Mitsutoshi Oguri, Kimihiko Kato, Kazuhiro Yajima, Takeshi Hibino, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Sahoko Ichihara, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa, Yoshiji Yamada.
    Assessment of the genetic component of hypertension.
    The 79th Scientific Sessions of American Heart Association, Chicago, USA, November 2006.

93. Sahoko Ichihara, Yoshiji Yamada, Kimihiko Kato, Takeshi Hibino, Kiyoshi Yokoi, Hitoshi Matsuo, Tomonori Segawa, Sachiro Watanabe, Hidemi Yoshida, Kei Satoh, Yoshinori Nozawa.
    Prediction of genetic risk for metabolic syndrome.
    The 79th Scientific Sessions of American Heart Association, Chicago, USA, November 2006.

94. Sahoko Ichihara, Gaku Ichihara, Yoshichika Kawai, Toshihiko Osawa, Yoshiji Yamada.
    Regulatory role of hypoxia-inducible factor-1α and redox-regulated transcription factor in doxorubicin cardiotoxicity.
    The 79th Scientific Sessions of American Heart Association, Chicago, USA, November 2006.

-2005-
95. Yoshiji Yamada.
    Genetic risk of coronary artery disease.
    Joint International Symposium of Cardiovascular Genomic Center and Yonsei University Research Institute of Science for Ageing, Yonsei University, Seoul, Korea, June 18, 2005.

96. Hideo Izawa, Sahoko Ichihara, Kenji Yasui, Fumimaro Takatsu, Haruo Hirayama, Makoto Watarai, Takahito Sone, Akira Yamada, Tomoko Kato, Hiroyuki Asano, Yoshiji Yamada, Toyoaki Murohara, Mitsuhiro Yokota.
    Identification of polymoriphisms in the microsomal triglyceride transfer protein and glutamate-cysteine ligase catalytic subunit genes as susceptibility loci for myocardial infarction.
    The 54th Annual Scientific Session of American College of Cardiology, Orlando, USA, March 2005.

97. Sahoko Ichihara, Gaku Ichihara, Li Ping, Yoshiji Yamada.
    A role of aryl hydrocarbon receptor in the regulation of angiogenesis.
    The 78th Scientific Sessions of American Heart Association, Dallas, USA, November 2005.

98. Yutaka Nishigaki, Noriyuki Fuku, Yoshiji Yamada, Masashi Tanaka.
    Japanese women with mitochondrial haplogroup N9a are protected against atherothrombotic cerebral infarction.
    International Conference on Mitochondria and Life 2005, Tokyo, Japan, December 2005.

99. Yutaka Nishigaki, Noriyuki Fuku, Yoshiji Yamada, Masashi Tanaka.
    Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese men.
    International Conference on Mitochondria and Life 2005, Tokyo, Japan, December 2005.

100. Masashi Tanaka, Yutaka Nishigaki, Noriyuki Fuku, Yasunori Fujita, Masafumi Ito, Yoshinori Nozawa, Takeshi Takeyasu, Kazunori Shimada, Yoshiji Yamada.
     Women with mitochondrial haplogroup N9a are protected against metabolic syndrome.
     International Conference on Mitochondria and Life 2005, Tokyo, Japan, December 2005.

101. Noriyuki Fuku, Yutaka Nishigaki, Yoshiji Yamada, Masashi Tanaka.
     Mitochondrial haplogroups F, A, and D4l are genetic risk factors for type 2 diabetes in women.
     International Conference on Mitochondria and Life 2005, Tokyo, Japan, December 2005.

-2004-
102. Yoshiji Yamada.
     Prediction of the genetic risk for coronary artery disease.
     First International Symposium of the Korean Association of Human Genomic Research Centers, Catholic University, Seoul, Korea, February 20, 2004.

-2003-
103. Hideo Izawa, Yoshiji Yamada, Hideki Horibe, Tomoko Kato, Sahoko Ichihara, Fumimaro Takatsu, Toyoaki Murohara, Mitsuhiro Yokota.
     Genetic risk diagnosis system for restenosis after percutaneous coronary intervention.
     The 52nd Annual Scientific Session of American College of Cardiology, Chicago, USA, March 2003.

104. Katsuhiko Kohara, Michiko Fujisawa, Fujiko Ando, Yasuharu Tabara, Naoakira Niino, Yoshiji Yamada, Tetsuro Miki, Hiroshi Shimokata.
     Matrix metallopeptidase gene polymorphisms and pulse pressure in a large Japanese general population.
     Eighteenth Annual Scientific Meeting of American Society of Hypertension, New York, USA, May 2003.

105. Yosuke Murase, Yoshiji Yamada, Sahoko Ichihara, Akira Yamada, Tomoko Kato, Hideo Izawa, Kohzo Nagata, Toyoaki Murohara, Mitsuhiro Yokota.
     Genetic risk and gene-environment interaction in coronary artery spasm.
     The 76th Scientific Sessions of American Heart Association, Orlando, USA, November 2003.

106. Tomoko Kato, Akira Yamada, Yohsuke Murase, Akihiro Hirashiki, Akiko Noda, Mitsuhiro Iwase, Yoshiji Yamada.
     Specific gene polymorphisms could be risk factors for coronary artery disease in individuals with or without hypertension.
     The 76th Scientific Sessions of American Heart Association, Orlando, USA, November 2003.

-2002-
107. Mari Odashima, Kohzo Nagata, Koji Obata, Fuji Somura, Jun Sasamori, Hideo Izawa, Mitsunori Iwase, Takao Nishizawa, Hisao Seo, Yoshiji Yamada, Mitsuhiro Yokota.
     ZAKI-4β as an endogenous inhibitor of cardiac hypertrophy: inhibition of calcineurin activity by ZAKI-4β and its expression independent of ZAKI-4α and DSCR1 in cultured rat cardiomyocytes.
     Scientific Conference on Advances in the Molecular and Cellular Mechanisms of Heart Failure, Snowbird, USA, August 2002.

108. Yoshiji Yamada, Hideo Izawa, Sahoko Ichihara, Fumimaro Takatsu, Hitoshi Ishihara, Haruo Hirayama, Takahito Sone, Masashi Tanaka, Mitsuhiro Yokota.
     Genetic risk diagnosis system for myocardial infarction developed by a large-scale association study of 112 gene polymorphisms in 5061 individuals.
     The 75th Scientific Sessions of American Heart Association, Chicago, USA, November 2002.

109. Sahoko Ichihara, Yoshiji Yamada, Takaaki Senbonmatsu, Tadashi Inagami.
     The targeted deletion of angiotensin II type 2 receptor caused cardiac rupture after acute myocardial infarction.
     The 75th Scientific Sessions of American Heart Association, Chicago, USA, November 2002.

-2001-
110. Masashi Tanaka, Harm-Jan Borgeld, Jin Zhang, Masayo Shamoto, Noriyuki Fuku, Miyuki Kurata, Yoshiji Yamada, Kumi Nishizawa, Yukihiro Akao.
     Gene therapy for mitochondrial cardiomyopathy.
     WHF/ISCP Joint International Symposium on Cardiomyopathy in the 21st Century, Kyoto, Japan, March 2001.

111. Yoshiji Yamada.
     Association of gene polymorphisms with genetic susceptibility to coronary artery disease.
     The Fifth International Conference on Preventive Cardiology, Osaka, Japan, May 2001.

112. Yoshiji Yamada.
     Plasma platelet-activating factor acetylhydrolase and atherosclerosis.
     The Seventh International Congress of Platelet-activating Factor and Lipid Mediators, Tokyo, Japan, September 2001.

113. Yoshiji Yamada, Makoto Hase, Masashi Tanaka, Mitsuhiro Yokota.
     Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the plasma platelet-activating factor acetylhydrolase gene into skeletal muscle.
     The 74th Scientific Sessions of American Heart Association, Anaheim, USA, November 2001.

-2000-
114. Fuji Somura, Ryoji Ishiki, Hideo Izawa, Motomu Terasawa, Kohzo Nagata, Mitsunori Iwase, Yoshiji Yamada, Masafumi Koide, Mitsuhiro Yokota.
     Subcellular mechanisms of the biphasic force-frequency relation in patients with left ventricular hypertrophy.
     The 73th Scientific Sessions of American Heart Association, New Orleans, USA, November 2000.

-1999-
115. Yoshiji Yamada.
     Prediction of the outcome of therapy with active vitamin D for postmenopausal osteoporosis by transforming growth factor- β1 genotype.
     The 4th NILS Workshop, Obu, Japan, December 1999.

116. Sahoko Ichihara, Yoshiji Yamada, Hitoshi Ishihara, Mitsuhiro Yokota.
     Phenotypic variation of familial hypertrophic cardiomyopathy caused by Phe¹¹⁰ →Ile mutation in the cardiac troponin T.
     The 72th Scientific Sessions of American Heart Association, Atlanta, USA, November 1999.

117. Mitsuhiro Yokota, Masafumi Inagaki, Hideo Izawa, Ryoji Ishiki, Kohzo Nagata, Mitsunori Iwase, Yoshiji Yamada, Masafumi Koide.
     The biphasic force-frequency relation is a possible marker of the transition from physiological to pathological hypertrophy.
     The 72th Scientific Sessions of American Heart Association, Atlanta, USA, November 1999.

-1998-
118. Sahoko Ichihara, Yoshiji Yamada, Takaharu Fujimura, Mitsuhiro Yokota.
     Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population.
     The 47th Annual Scientific Session of American College of Cardiology, Atlanta, USA, April 1998.

119. Sahoko Ichihara, Yoshiji Yamada, Mitsuhiro Yokota.
     Association of polymorphisms of manganese superoxide dismutase and plasma platelet-activating factor acetylhydrolase genes with genetic susceptibility to nonfamilial dilated cardiomyopathy.
     The 47th Annual Scientific Session of American College of Cardiology, Atlanta, USA, April 1998.

120. Yoshiji Yamada, Atsushi Harada, Akimitsu Miyauchi, Junki Goto, Takayuki Hosoi, Fukashi Makimoto, Hiroyuki Tanaka, Yoshiki Seino, Koji Ikeda.
     Identification of a polymorphism of the TGF-β1 gene as a genetic determinant of the bone mass and a susceptibility factor to osteoporosis.
     Second Joint Meeting of the American Society for Bone and Mineral Research and the International Bone and Mineral Society, San Francisco, USA, December 1998.

121. Hiroyuki Takai, Masahiro Kanematsu, Kazuki Yano, Eisuke Tsuda, Kanji Higashio, Kyoji Ikeda, Ken Watanabe, Yoshiji Yamada.
     TGF-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
     Second Joint Meeting of the American Society for Bone and Mineral Research and the International Bone and Mineral Society, San Francisco, USA, December 1998.

122. Masahiro Kanematsu, Hiroyuki Takai, Takuya Sato, Ken Watanabe, Kyoji Ikeda, Yoshiji Yamada.
     RANKL induced on pre-B cells by prostaglandin E₂ may be involved in the pathogenesis of osteoporosis.
     Second Joint Meeting of the American Society for Bone and Mineral Research and the International Bone and Mineral Society, San Francisco, USA, December 1998.

-1997-
123. Masahiro Kanematsu, Kyoji Ikeda, Yoshiji Yamada.
     Diverse actions of nitric oxide in the regulation of osteoclastic and osteoblastic functions.
     The 19th Annual Meeting of American Society for Bone and Mineral Research, Cincinnati, USA, September 1997.

124. Yoshiji Yamada, Sahoko Ichihara, Takaharu Fujimura, Mitauhiro Yokota.
     Identification of the G⁹⁹⁴→T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.
     The 70th Scientific Sessions of American Heart Association, Orlando, USA, November 1997.

-1996-
125. Takaharu Fujimura, Yoshiji Yamada, Mitsuhiro Yokota.
     Deletion polymorphism of angiotensin-converting enzyme gene is an independent risk factor for coronary atherosclerosis in middle-aged Japanese men; a multicenter study of 2656 examinations.
     The 18th Congress of the European Society of Cardiology, Birmingham, UK, August 1996.

126. Mitsuhiro Yokota, Takaharu Fujimura, Toshikazu Sobue, Yoshiji Yamada.
     Deletion polymorphism of angiotensin-converting enzyme gene is an independent risk factor for coronary atherosclerosis in middle-aged Japanese men; a multicenter study of 2656 individuals.
     The 69th Scientific Sessions of American Heart Association, New Orleans, USA, November 1996.

-1993-
127. Yoshiji Yamada, Stephen M. Prescott.
     Study of human platelet-activating factor acetylhydrolase using Xenopus oocytes.
     Nagoya-Salt Lake City Joint Seminar on Cardiology, Salt Lake City, USA, July 1993.

-1992-
128. Yoshiji Yamada, Diana M. Stafforini, Laurence A. Fitzgerald, Guy A. Zimmerman, Thomas M. McIntyre, Stephen M. Prescott.
     Human platelet-activating factor acetylhydrolase expressed in Xenopus oocytes.
     1992 The Annual Meeting of the Association of American Physicians/American Society for Clinical Investigation/American Federation for Clinical Research, Baltimore, USA, May 1992.

129. Yoshiji Yamada, Diana M. Stafforini, Laurence A. Fitzgerald, Guy A. Zimmerman, Thomas M. McIntyre, Stephen M. Prescott.
     Human platelet-activating factor acetylhydrolase expressed in Xenopus oocytes.
     4th International Congress on PAF and Related Lipid Mediators, Snowbird, USA, September 1992.

-1989-
130. Toshikazu Suzuki, Kazunobu Yamauchi, Yoshiji Yamada, Takeo Furumichi, Hirohiko Furui, Jitsuki Tsuzuki, Hiroshi Hayashi, Iwao Sotobata, Hidehiko Saito.
     A study on blood coagulability and fibrinolytic activity before and after physical training in patients with acute myocardial infarction.
     XIIth Congress of the International Society on Thrombosis and Haemostasis, Tokyo, Japan, August 1989.

-1986-
131. Hiroshi Hayashi, Kazuhide Takami, Tomihisa Ishikawa, Yoshiji Yamada, Seitaro Yabe, Haruki Kojima, Kyoichi Miyachi, Iwao Sotobata.
     Protection from ischemic injury by nifedipine in patients with acute anterior myocardial infarction estimated by body surface map.
     Xth World Congress of Cardiology, Washington, D.C., USA, September 1986.

Copyright © 2004-2007 Department of Human Functional Genomics. All rights reserved.